C12N 2795/10151
Methods of production or purification of viral material
C12N2795/10151 (Methods of production or purification of viral material) appears on 28 US grants and 42 published applications in this corpus.
Search patents in C12N- Granted patents
- 28
- Published applications
- 42
- Assignees
- 26
- Inventors
- 86
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 1 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 3 |
| 2012 | 0 | 0 |
| 2013 | 0 | 2 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 5 | 3 |
| 2017 | 3 | 3 |
| 2018 | 2 | 0 |
| 2019 | 3 | 3 |
| 2020 | 0 | 5 |
| 2021 | 2 | 3 |
| 2022 | 2 | 6 |
| 2023 | 2 | 4 |
| 2024 | 2 | 1 |
| 2025 | 2 | 1 |
| 2026 | 3 | 2 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for purifying bacteriophage and products of manufacture containing endotoxin-free bacteriophage preparations9 Jun 2026US 12,648,976 B2San Diego State University (SDSU) Foundation
- Microencapsulation of bacteriophages and related products28 Apr 2026US 12,611,435 B2Precisio Biotix Therapeutics, Inc.
- Systems and methods for generating bacteriophages adapted to infect a target bacterial strain17 Mar 2026US 12,577,538 B2Baylor College of Medicine
- Method for depletion or removal of endotoxin from an endotoxin-containing source or potentially endotoxin-containing source9 Dec 2025US 12,492,383 B2Sartorius BIA Separations d.o.o.
- Bacteriophage-based artificial viruses for human genome remodeling4 Mar 2025US 12,241,080 B2The Catholic University of America
- Systems and methods for generating bacteriophages adapted to infect a target bacterial strain20 Aug 2026US 2026/0242749 A1Baylor College of Medicine
- Methods for purifying bacteriophage and products of manufacture containing endotoxin-free bacteriophage preparations23 Jul 2026US 2026/0207688 A1San Diego State University (Sdsu) Foundation, Dba San Diego State University Research Foundation
- Bacteriophage7 Aug 2025US 2025/0249085 A1Glaxosmithkline Biologicals SA
- Method for purification of bacteriophage particles22 Aug 2024US 2024/0279620 A1Adaptive Phage Therapeutics, Inc.
- Phage and transduction particles19 Oct 2023US 2023/0330167 A1SNIPR Biome ApS
Most cited
By later US patents
- Non-replicative transduction particles and transduction particle-based reporter systems11US 9,388,453 B2GeneWeave Biosciences, Inc. · 2016
- Immobilisation and stabilisation of virus7US 7,482,115 B2University of Strathclyde · 2009
- Bacteriophage-based artificial viruses for human genome remodeling5US 11,401,530 B2The Catholic University of America · 2022
- Non-replicative transduction particles and transduction particle-based reporter systems4US 9,771,622 B2GeneWeave Biosciences, Inc. · 2017
- Method of long-term preservation of chemical and biological species using sugar glasses1US 11,040,015 B2McMaster University · 2021